Snowball logo
logo
NAVB_logo

Navidea Biopharmaceuticals Inc

$0.0001$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20192020202120222023
Revenue
Total revenue
0.02660.9150130.5315130.06570.00061
COGS
0.0066670.0010480.1988340.1849470.05
Gross Profit
0.020.9139650.332679(0.119295)(0.0494)
Operating Expenses & Income
Operating Income
(10.96)(10.71)(12.06)(14.05)(10.18)
Total Operating Expenses
10.9811.6312.3913.9310.13
R&D Expenses
5.3382674.9301875.141915.9697745.093444
Selling General & Admin Expenses
6.2754096.6949597.4500157.9618265.036755
Earnings from Continuing Operations
Interest Expense
(0.0253)(0.0113)(0.006361)(1.098322)-
Interest Income
0.02530.0113---
Income Tax Expense
0.000707(0.0817)0.0162.037883(8.020575)
Net Income
Net Income
(10.95)(10.64)(11.73)(17.22)(1.18248)
Supplemental
EBIT
(10.96)(10.71)(11.71)(14.05)(10.77)
EBITDA
(10.82)(10.64)(11.51)(13.96)(10.66)
In millions of USD, except % and values per 1 share